Difference between revisions of "Bevacizumab"
Jump to navigation
Jump to search
| Line 6: | Line 6: | ||
{{Reflist|1}} | {{Reflist|1}} | ||
[[Category:Clinical]] | |||
[[Category:Drugs]] | [[Category:Drugs]] | ||
Latest revision as of 15:34, 20 October 2014
Bevacizumab is an antibody that targets VEGF.[1]
It was first used in colorectal carcinoma but now used for a number of other tumours.[2]
References
- ↑ Toon, CW.; Hasovits, C.; Paik, J.; Field, M.; Chou, A.; Hugh, TJ.; Pavlakis, N.; Gill, AJ. (Jul 2014). "Skin rash, a kidney mass and a family mystery dating back to World War II.". Med J Aust 201 (1): 58-60. PMID 24999901.
- ↑ URL: http://www.nlm.nih.gov/medlineplus/druginfo/meds/a607001.html. Accessed on: October 20, 2014.